Molnovir 200 | Sana Pharma
Molnovir 200
Home » Medicinal Products » Molnovir 200

Molnupiravir 200 mg


Molnovir 200 mg is an oral antiviral drug for emergency treatment of mild to moderate Covid-19 patients. U.S. FDA approved for emergency treatment of adult patients infected with the SARS-CoV-2 (COVID-19) virus and at risk for severe progression.


Using Molnovir to treat patients with COVID-19 showed significant clinical outcomes including:


  • The first oral antiviral drug that is directly effective in attenuating viral RNA and SARS-CoV-2 in the nasopharynx.
  • Convenient short-term treatment (5 days).
  • Decreases the risk of hospitalization and mortality in adult patients suffering from mild-to-moderate COVID-19.
  • Reduces patient’s risks of receiving mechanical ventilation.
  • Effective against SARS-CoV-2 variants.
  • Safe and well-tolerated.